Skip navigation

Calls to Action

Vaccines

Many studies have examined possible links between vaccination and increased prevalence of autism. This research has paid particular attention to the measles-mumps-rubella (MMR) vaccine, vaccines containing thimerosal and the total number of vaccines administered during early childhood or any one doctor’s visit. These studies have not found a link between vaccines and autism.

Latest Study Finds No Association
July 12, 2006

The Institute of Medicine (IOM) of the National Academies has issued its latest report examining whether vaccines, specifically the measles, mumps, rubella (MMR) vaccine and those containing the preservative, thimerosal, are linked to the cause of autism.


Click here
to view the IOM Report.

Archive
Autism Speaks, Get Involved, In the News, NAAR Archive, IOM Reports on Vaccines and Autism
Latest Study Finds No Association
April 23, 2007

The Institute of Medicine (IOM) of the National Academies has issued its latest report examining whether vaccines, specifically the measles, mumps, rubella (MMR) vaccine and those containing the preservative, thimerosal, are linked to the cause of autism.


Click here
to view the IOM Report.

Archive
Autism Speaks, Get Involved, In the News, NAAR Archive, IOM Reports on Vaccines and Autism
New Webpages are a Useful Resource for Parents and Professionals
April 23, 2007

The website of the Centers for Disease Control and Prevention (CDC) has recently added useful information regarding thimerosal and vaccines and how they relate to autism, including many common questions about thimerosal, the MMR vaccine and autism.

Click here to visit the CDC's page on thimerosal, vaccines and autism.

Archive
Autism Speaks, Get Involved, In the News, NAAR Archive, CDC Website on Vaccines & Autism
First ever test case underway in Washington DC
June 27, 2007

The U.S. Court of Federal Claims is now hearing the first test case alleging that children have contracted autism as a result of vaccines. The hearings, which are focused on claims from among more than 4,800 filed against the federal government during the past six years, began on June 11, 2007.

To follow the proceedings, read transcripts or listen to audio of the hearings, visit the court's web site.

Archive
Autism Speaks, In the News, Current News, Federal Claims Court Continues Hearings in Case Against Vaccines
First ever test case to be heard in Washington DC
June 07, 2007


On Monday, June 11, the U.S. Court of Federal Claims will hear the first test case from among more than 4,800 claims filed against the federal government during the past six years alleging that children have contracted autism as a result of vaccines. To learn more,
click here.

Archive
Autism Speaks, In the News, Current News, Case Against Vaccines goes to U.S. Court of Federal Claims
March 17, 2008

An article in the The New York Times on March 18 features Autism Speaks President Mark Roithmayr, who says "I'm not a famous person, but my lapel pin makes me feel like one," and describes his encounters with people he meets while traveling and wearing the Autism Speaks Puzzle Pin in his lapel. Click here to read the article from the New York Times.

Archive
Autism Speaks, In the News, Current News, Letting His Lapel Spread the Word About His Cause
March 05, 2008


By MARILYNN MARCHIONE, Associated Press

Medical and legal experts say the narrow wording and circumstances probably make the case an exception — not a precedent for thousands of other pending claims.

Archive
Autism Speaks, In the News, Current News, Government Concedes Vaccine Injury Case
February 06, 2009

Washington, DC (February 6, 2009) - The Interagency Autism Coordinating Committee (IACC) addressed the removal of two objectives on vaccine safety research that were withdrawn from a National Institutes of Health strategic plan at its last meeting. Because of the manner in which the objectives were withdrawn, without adequate notice to the committee and public, Autism Speaks had previously voiced its disappointment and withdrew its support from the strategic plan.